Scarica l'app Stockscreener
1.5912
2.90%
0.0412
Precedente Chiudi:
$1.55
Aprire:
$1.55
Volume 24 ore:
544.05K
Relative Volume:
1.04
Capitalizzazione di mercato:
$64.79M
Reddito:
$68.68M
Utile/perdita netta:
$-60.84M
Rapporto P/E:
-0.9945
EPS:
-1.6
Flusso di cassa netto:
$-38.42M
1 W Prestazione:
-2.74%
1M Prestazione:
-45.00%
6M Prestazione:
-77.25%
1 anno Prestazione:
-72.02%
Intervallo 1D:
$1.5406
$1.60
Intervallo di 1 settimana:
$1.53
$1.705
Portata 52W:
$1.53
$9.37
Pulmonx Corp Stock (LUNG) Company Profile
Nome
Pulmonx Corp
Settore
Industria
Telefono
650-364-0400
Indirizzo
700 CHESAPEAKE DRIVE, REDWOOD CITY
Confronta LUNG con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LUNG
Pulmonx Corp
|
1.59 | 63.16M | 68.68M | -60.84M | -38.42M | -1.60 |
|
ABT
Abbott Laboratories
|
130.55 | 233.71B | 43.11B | 13.98B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
101.94 | 152.83B | 18.49B | 2.51B | 3.23B | 1.68 |
|
SYK
Stryker Corp
|
375.67 | 144.35B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
91.77 | 119.00B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
76.90 | 46.00B | 5.69B | 4.14B | 577.90M | 6.96 |
Pulmonx Corp Stock (LUNG) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-31 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2025-03-10 | Iniziato | D. Boral Capital | Buy |
| 2024-12-11 | Downgrade | Citigroup | Buy → Neutral |
| 2024-06-04 | Iniziato | Lake Street | Buy |
| 2024-02-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2023-09-05 | Iniziato | Craig Hallum | Buy |
| 2023-02-27 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2023-01-03 | Downgrade | BofA Securities | Neutral → Underperform |
| 2022-12-12 | Aggiornamento | Citigroup | Neutral → Buy |
| 2022-07-11 | Downgrade | Citigroup | Buy → Neutral |
| 2022-03-02 | Ripresa | BofA Securities | Neutral |
| 2021-12-08 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2021-04-01 | Iniziato | Citigroup | Buy |
| 2021-03-25 | Iniziato | Piper Sandler | Neutral |
| 2021-03-10 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2021-01-04 | Downgrade | BofA Securities | Buy → Neutral |
| 2020-10-26 | Iniziato | BofA Securities | Buy |
| 2020-10-26 | Iniziato | Canaccord Genuity | Buy |
| 2020-10-26 | Iniziato | Morgan Stanley | Equal-Weight |
| 2020-10-26 | Iniziato | Stifel | Buy |
| 2020-10-26 | Iniziato | Wells Fargo | Equal Weight |
Mostra tutto
Pulmonx Corp Borsa (LUNG) Ultime notizie
Pulmonx at Canaccord Conference: Growth Plans Amid Challenges By Investing.com - Investing.com South Africa
Pulmonx Corporation stock trend outlook and recovery pathFree Trend Analysis for Safer Trades - Newser
Chart based exit strategy for Pulmonx CorporationFree Smart Trend Trading with Weekly Signals - Newser
Developing predictive dashboards with Pulmonx Corporation dataFuture Growth Stock Forecasting Strategy - Newser
After Plunging 37.5% in 4 Weeks, Here's Why the Trend Might Reverse for Pulmonx (LUNG) - Yahoo Finance
What momentum shifts mean for Pulmonx CorporationTechnical Insight Guide for Safer Trades - Newser
What catalysts could drive Pulmonx Corporation stock higher in 2025Triple-digit returns - Jammu Links News
Pulmonx (NASDAQ:LUNG) Cut to Neutral at Piper Sandler - Defense World
Pulmonx (LUNG) Q2 Revenue Rises 15% - AOL.com
What the charts say about Pulmonx Corporation todayFree Triple Return Setup with Risk Control - Newser
Analysts Have Lowered Expectations For Pulmonx Corporation (NASDAQ:LUNG) After Its Latest Results - 富途牛牛
Pulmonx Corp SEC 10-Q Report - TradingView
Pulmonx Corporation (NASDAQ:LUNG) Q2 2025 Earnings Call Transcript - Insider Monkey
Pulmonx Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Pulmonx Corp (LUNG) Stock: 52-Week Performance Showcases Highs, Lows, and Trading Volume - investchronicle.com
Nasdaq Surges Over 1%; Microsoft Posts Upbeat Earnings - Benzinga
Will GRDN price bounce be sustainableStrong Buy Opportunity with Volume Support - Newser
Should I buy Riverview Bancorp Inc. stock before earningsReal-Time AI Sentiment and Price Forecast - Newser
Pulmonx Corp (LUNG) Q2 2025 Earnings Call Highlights: Strong International Growth Amid US Challenges - Yahoo Finance
Piper Sandler downgrades Pulmonx stock to Neutral on growth concerns - Investing.com India
Piper Sandler downgrades Pulmonx stock to Neutral on growth concerns By Investing.com - Investing.com Nigeria
What to expect from Pulmonx Corporation in the next 30 daysSwing Gain Strategy with Entry Forecast - Newser
CNB Financial Corporation stock retracement – recovery analysisPortfolio Risk Distribution Analysis Tool - Newser
Is Canada Goose Holdings Inc. showing signs of accumulationWeekly Return Plan for Conservative Traders - Newser
Tools to monitor Pulmonx Corporation recovery probabilityFree Real-Time Analysis With Entry Targets - Newser
Earnings call transcript: Pulmonx reports Q2 2025 revenue beat, stock gains - Investing.com Canada
Earnings call transcript: Pulmonx reports Q2 2025 revenue beat, stock gains By Investing.com - Investing.com South Africa
Pulmonx Corp reports results for the quarter ended June 30Earnings Summary - TradingView
Pulmonx earnings beat by $0.02, revenue topped estimates - Investing.com Canada
Option Care Health Inc. Building a Base Near SupportBreakout Confirmation With Entry Tracker Enabled - metal.it
Can trapped investors hope for a rebound in Sally Beauty Holdings Inc.Intraday Price Forecast Using Volume Models - Newser
Is Delek US Holdings Inc. stock ready for a breakoutVolume Confirmed Setup with Entry Confidence - Newser
Leading Lung Disease Treatment Company Pulmonx Showcases Growth Story at Major Healthcare Conference - Stock Titan
Why SL Green Realty Corp. stock is on top investor watchlistsSector Rotation and Stock Opportunity Analysis - Newser
Price Channel Expanding on Pulmonx Corporation’s ChartCapital Preserving Trade Plan Templates Shared - metal.it
Pulmonx Corp expected to post a loss of 40 cents a shareEarnings Preview - TradingView
Pulmonx (LUNG) Projected to Post Quarterly Earnings on Wednesday - Defense World
Pulmonx Corporation Stock Support and Resistance Levels You Should KnowWeekly Double Return List - metal.it
What makes HFBL stock price move sharplyInsider Strategy Insight - Newser
How Pulmonx Corporation stock performs during market volatilityWeekly Stock Picks with Trend Confidence - Newser
Earnings Preview: Pulmonx to Report Financial Results Post-market on July 30 - 富途牛牛
What analysts say about Pulmonx Corporation stockExceptional growth trajectory - jammulinksnews.com
Is Pulmonx Corporation a good long term investmentUnprecedented growth rates - jammulinksnews.com
What drives Pulmonx Corporation stock priceSuperior return velocity - jammulinksnews.com
Can Spring Valley Acquisition Corp. II Equity Right stock recover from recent declineDaily Breakout Picks - Newser
Pulmonx to Report Second Quarter 2025 Financial Results on July 30, 2025 - The Manila Times
Pulmonx Sets Q2 Earnings Date: Leading Lung Disease Treatment Maker to Update Investors July 30 - Stock Titan
Why Pulmonx Corporation stock attracts strong analyst attentionChart Based Entries - Newser
What makes Pulmonx Corporation stock price move sharplyBreakout Confirmation Tool - Newser
Pulmonx Corp Azioni (LUNG) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.31%
0.66%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):